The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

Novo's earnings results Wednesday differ from Eli Lilly's, whose stock slid on slower-than-expected sales of weight loss ...

Shares of Google parent Alphabet slump after quarterly revenue misses analysts’ expectations, AMD’s data-center revenue ...

Shares in Google-parent Alphabet (GOOGL, GOOG) tumbled in after-hours trading following the release of the tech giant's ...

Vietnam’s pharmaceutical market is expected to have a year of optimism after experiencing a multicoloured gamut in 2024.

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Centene beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strength in its commercial health ...

The number of prescriptions for obesity medications rose an average of 5.3% annually from 2017 to 2024 and corresponded with ...

Most Wall Street professionals obsess over short-term returns. However, patient individual investors who buy and hold leading ...

The New York telecommunications giant's quarterly earnings beat Wall Street forecasts as higher prices helped to boost revenue. The Fed is seen as likely to leave rates unchanged in January, but the ...